Literature DB >> 27444354

Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Zhiping Mi1, Willi Halfter1, Eric E Abrahamson1, William E Klunk1, Chester A Mathis1, Elliott J Mufson1, Milos D Ikonomovic2.   

Abstract

Tenascin-C (TN-C) is an extracellular matrix glycoprotein linked to inflammatory processes in pathological conditions including Alzheimer disease (AD). We examined the distribution of TN-C immunoreactivity (ir) in relation to amyloid-β (Aβ) plaques and vascular Aβ deposits in autopsy brain tissues from 14 patients with clinical and neuropathological AD and 10 aged-matched controls with no cognitive impairment; 5 of the controls had Aβ plaques and 5 did not. TN-C ir was abundant in cortical white matter and subpial cerebral gray matter in all cases, whereas TN-C ir was weak in blood vessels. In all cases with Aβ plaques but not in plaque-free controls, TN-C ir was detected as large (>100 µm in diameter) diffuse extracellular deposits in cortical grey matter. TN-C plaques completely overlapped and surrounded cored Aβ plaques labeled with X-34, a fluorescent derivative of Congo red, and they were associated with reactive astrocytes astrocytes, microglia and phosphorylated tau-containing dystrophic neurites. Diffuse Aβ plaques lacking amyloid cores, reactive glia or dystrophic neurites showed no TN-C ir. In cases with cerebral amyloid angiopathy, TN-C ir in vessel walls did not spread into the surrounding neuropil. These results suggest a role for TN-C in Aβ plaque pathogenesis and its potential as a biomarker and therapy target.
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Astrocytes; Extracellular matrix; Inflammation; Microglia; Tau; Tenascin; β-amyloid

Mesh:

Substances:

Year:  2016        PMID: 27444354      PMCID: PMC5909866          DOI: 10.1093/jnen/nlw062

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  72 in total

1.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 2.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

3.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse.

Authors:  Hiroki Nakahara; Esteban C Gabazza; Hajime Fujimoto; Yoichi Nishii; Corina N D'Alessandro-Gabazza; Nelson E Bruno; Takehiro Takagi; Tatsuya Hayashi; Junko Maruyama; Kazuo Maruyama; Kyoko Imanaka-Yoshida; Koji Suzuki; Toshimichi Yoshida; Yukihiko Adachi; Osamu Taguchi
Journal:  Eur J Immunol       Date:  2006-12       Impact factor: 5.532

6.  Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells.

Authors:  W W Zhang; H Lempessi; Y Olsson
Journal:  Acta Neuropathol       Date:  1998-12       Impact factor: 17.088

Review 7.  Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications.

Authors:  Piet Eikelenboom; Rob Veerhuis; Atoosa Familian; Jeroen J M Hoozemans; Willem A van Gool; Annemieke J M Rozemuller
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977

8.  Induction of tenascin in healing wounds.

Authors:  E J Mackie; W Halfter; D Liverani
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

Review 9.  Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage.

Authors:  Lars Roll; Andreas Faissner
Journal:  Front Cell Neurosci       Date:  2014-08-19       Impact factor: 5.505

10.  Tenascin-C signaling through induction of 14-3-3 tau.

Authors:  Doris Martin; Marianne Brown-Luedi; Ruth Chiquet-Ehrismann
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

View more
  11 in total

Review 1.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

2.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Authors:  Eleanor Drummond; Shruti Nayak; Arline Faustin; Geoffrey Pires; Richard A Hickman; Manor Askenazi; Mark Cohen; Tracy Haldiman; Chae Kim; Xiaoxia Han; Yongzhao Shao; Jiri G Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2017-03-04       Impact factor: 15.887

3.  Impaired Fear Extinction Due to a Deficit in Ca2+ Influx Through L-Type Voltage-Gated Ca2+ Channels in Mice Deficient for Tenascin-C.

Authors:  Fabio Morellini; Aleksey Malyshev; Maxim Volgushev; Marina Chistiakova; Giorgi Papashvili; Laetitia Fellini; Ralf Kleene; Melitta Schachner; Alexander Dityatev
Journal:  Front Integr Neurosci       Date:  2017-08-02

Review 4.  Pleiotropic Role of Tenascin-C in Central Nervous System Diseases: From Basic to Clinical Applications.

Authors:  Chen Hanmin; Zhou Xiangyue; Cameron Lenahan; Wang Ling; Ou Yibo; He Yue
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

5.  Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model.

Authors:  Susanne Wiemann; Jacqueline Reinhard; Sabrina Reinehr; Zülal Cibir; Stephanie C Joachim; Andreas Faissner
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

6.  Associations Between Tenascin-C and Testosterone Deficiency in Men with Major Depressive Disorder: A Cross-Sectional Retrospective Study.

Authors:  Rui Peng; Yan Li
Journal:  J Inflamm Res       Date:  2021-03-16

7.  Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.

Authors:  Christof Haffner; Martin Dichgans; Andreas Zellner; Stephan A Müller; Barbara Lindner; Nathalie Beaufort; Annemieke J M Rozemuller; Thomas Arzberger; Nils C Gassen; Stefan F Lichtenthaler; Bernhard Kuster
Journal:  Acta Neuropathol Commun       Date:  2022-01-24       Impact factor: 7.801

8.  Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth.

Authors:  Yi-Jun Wang; Matthew A Downey; Sungwoon Choi; Timothy M Shoup; David R Elmaleh
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

Review 9.  Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Authors:  Zaixiang Fu; Ganggui Zhu; Chao Luo; Zihang Chen; Zhangqi Dou; Yike Chen; Chen Zhong; Sheng Su; Fuyi Liu
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

10.  Collective feature selection to identify crucial epistatic variants.

Authors:  Shefali S Verma; Anastasia Lucas; Xinyuan Zhang; Yogasudha Veturi; Scott Dudek; Binglan Li; Ruowang Li; Ryan Urbanowicz; Jason H Moore; Dokyoon Kim; Marylyn D Ritchie
Journal:  BioData Min       Date:  2018-04-19       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.